Why the study?
Behavioural activation reduces depressive symptoms in older adults, but whether an increase in physical activity mediates these effects remains unknown.
Does physical activity mediate the reduction of depressive symptoms in older adults treated with behavioural activation?
Does physical activity mediate the reduction of depressive symptoms in older adults treated with behavioural activation?
Physical activity does not mediate the reduction in depressive symptoms seen with behavioural activation in older adults, though increased physical activity is independently associated with improved symptoms.
Physical activity does not mediate behavioural activation benefits on depressive symptoms; confirms independent activity-symptom link regardless of treatment.
BACKGROUND: Behavioural activation reduces depressive symptoms in older adults but its working mechanisms remain unknown. Physical activity may play a role by decreasing depressive symptoms in older adults. We investigated whether an increase in physical activity explains the effects of behavioural activation on depressive symptoms in older adults. METHODS: Participants were 44 adults aged 65-88 years, who participated in a cluster randomised trial evaluating the effectiveness of an eight-week behavioural activation treatment (n = 25) compared with eight weeks of treatment as usual (TAU; n = 19) in primary care. Mediation analysis was used to evaluate whether the effects of behavioural activation on depression were mediated by physical activity as assessed by trunk accelerometer. RESULTS: = 0.075) with a decrease in depressive symptoms, regardless of type of treatment (p < 0.05). CONCLUSION: In this sample, physical activity did not explain the difference in effectiveness between behavioural activation and treatment as usual. In line with the literature, our results showed an association of a small increase in physical activity with a decrease in depressive symptoms, regardless of treatment modality. Larger studies are needed to replicate these findings. TRIAL REGISTRATION: Netherlands Trial Register, NL5436.
No takes yet. Share an insight, caveat, or question.
Janssen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: